News
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
Terry's nails, characterized by a white, frosted appearance with a narrow pink band, can indicate underlying health issues like liver cirrhosis, heart ...
New research highlights a significant link between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ...
Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...
1d
HealthDay on MSNWorse Emotional Health-Related QoL Seen for Women With Cirrhosis, Ascites
Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is ...
2don MSN
Liver Cirrhosis risk? Check your nails, this common condition might be telling you something
Terry's nails, a nail abnormality characterized by a white, frosted appearance with a reddish-brown band at the tip, can ...
The FDA has granted accelerated approval of Wegovy® (semaglutide) for adults with moderate to advanced metabolic ...
4h
News Medical on MSNCHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management
The identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how ...
Our nails often reflect more than just cosmetic health—they can serve as windows into hidden medical conditions. One such subtle yet significant sign is known as Terry’s nails, a condition that may ...
Epidemiological data on bacterial infections in cirrhosis in China remain limited. Therefore, we aimed to conduct a multicenter study to investigate the characteristics and outcomes of patients with ...
Epidemiological data on bacterial infections in cirrhosis in China remain limited. Therefore, we aimed to conduct a multicenter study to investigate ...
4d
MedPage Today on MSNSemaglutide Gets FDA Greenlight for MASH
The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results